Results 121 to 130 of about 13,683 (246)

Canadian Patients With Axial Spondyloarthritis Require Almost a Decade To Be Diagnosed Leading to Severe Functional Limitation. Results From the International Map of Axial Spondyloarthritis (IMAS)

open access: yesMusculoskeletal Care, Volume 22, Issue 4, December 2024.
ABSTRACT Objective To evaluate the sociodemographic characteristics and disease‐related factors associated with diagnostic delay in Canadian patients with axial spondyloarthritis (axSpA). Methods Data from 542 Canadian patients who participated in the International Map of Axial Spondyloarthritis online survey were analysed.
Proton Rahman   +13 more
wiley   +1 more source

Social role participation questionnaire for patients with ankylosing spondylitis: Translation into Dutch, reliability and construct validity [PDF]

open access: yes, 2016
Objective: The Social Role Participation Questionnaire (SRPQ) assesses the influence of health on participation in 11 specific and one general participation role across 4 participation dimensions: 'importance', 'satisfaction with time', 'satisfaction ...
Arends, S. (Suzanne)   +12 more
core   +1 more source

Patient-reported outcomes in European spondyloarthritis patients: a systematic review of the literature [PDF]

open access: yes, 2018
Objective: This review aims to summarize the current literature on patient-reported outcomes (PROs) in spondyloarthritis (SpA). Patients and methods: We performed a systematic literature review to identify studies (original articles and narrative and ...
Blanch, Carles   +4 more
core   +2 more sources

POS0023 PERFORMANCE OF BASDAI VS. ASDAS IN EVALUATING AXIAL INVOLVEMENT IN PATIENTS WITH PSA TREATED WITH GUSELKUMAB: POOLED ANALYSIS OF TWO PHASE 3 STUDIES [PDF]

open access: bronze, 2023
Xenofon Baraliakos   +8 more
openalex   +1 more source

results of the randomized, placebo-controlled GO-RAISE study [PDF]

open access: yes, 2016
Background In the present study, we evaluated relationships between serum biomarkers and clinical/magnetic resonance imaging (MRI) findings in golimumab-treated patients with ankylosing spondylitis.
Baraliakos, Xenofon   +7 more
core   +1 more source

Вміст циркулюючих ендотеліальних клітин в крові як маркер ендотеліальної дисфункції у хворих на анкілозивний спондилоартрит [PDF]

open access: yes, 2017
Актуальність: Відомо, що смертність серед пацієнтів з анкілозивним спондилоартритом (АС) в більшості випадків зумовлена сердцево-судинною патологією, яка в свою чергу опосердкована наявністю хронічного системного запалення, який вважають вагомим ...
Кошак, Б.А.
core  

Concomitância de fibromialgia em pacientes com espondilite anquilosante Occurrence of fibromyalgia in patients with ankylosing spondylitis

open access: yesRevista Brasileira de Reumatologia, 2010
INTRODUÇÃO: A Espondilite Anquilosante (EA) é uma doença inflamatória crônica que acomete o esqueleto axial. Cursa com dor e incapacidade funcional. Para medir o impacto da EA na vida dos pacientes são utilizados questionários que avaliam a atividade da ...
Valderilio Feijó Azevedo   +3 more
doaj   +1 more source

Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study. [PDF]

open access: yes, 2016
OBJECTIVE: To evaluate the effect of secukinumab, an interleukin-17A inhibitor, on clinical signs and symptoms and radiographic changes through 2 years in patients with ankylosing spondylitis (AS). METHODS: In the phase III MEASURE 1 study, patients were
Baeten, D   +10 more
core   +1 more source

Ocjena aktivnosti ankilozantnog spondilitisa primjenom BASDAI i ASDAS instrumenta

open access: yesReumatizam, 2012
Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) is the most frequently used ankylosing spondylitis activity assesment by which through 6 questions 5 basic diseases symptoms (fatigue, back pain, joint pain/swelling, enthesitic points, intensity and duration of morning stiffness) are being evaluated.
Kovač Durmiš, Kristina   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy